17084-02-5

Basic information

• Product Name: [N-[2-[bis(carboxymethyl)amino]ethyl]-N-(2-hydroxyethyl)glycinato(3-)]iron
• Synonyms: [N-[2-[bis(carboxymethyl)amino]ethyl]-N-(2-hydroxyethyl)glycinato(3-)]iron;Iron(2-), [N-[2-[bis(carboxy-.kappa.O)methyl]amino-.kappa.N]ethyl]-N-[2-(hydroxy-.kappa.O)ethyl}glycinate(3-)-.kappa.N,.kappa.O];iron, [n-[2-[bis(carboxymethyl)amino]ethyl]-n-(2-hydroxyethyl)glycinato(3-)];Iron, [N-[2-[bis[(carboxy-.kappa.O)methyl]amino-.kappa.N]ethyl]-N-[2-(hydroxy-.kappa.O)ethyl]glycinato(3-)-.kappa.N,.kappa.O];Ferric hedta;Iron, [[N-(carboxymethyl)-N'-(2-hydroxyethyl)-N,N'-ethylenediglycinato](3-)]-;Nsc97346
• CAS NO: 17084-02-5
• Molecular Formula: C₁₀H₁₅N₂O₇*Fe
• Molecular Weight: 334.103
• EINECS: 241-142-5
• Mol File: 17084-02-5.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 572.5 °C at 760 mmHg
• Flash Point: 300 °C
• Appearance: /
• Density: g/cm³
• Vapor Pressure: 1.72E-15mmHg at 25°C
• CAS DataBase Reference: [N-[2-[bis(carboxymethyl)amino]ethyl]-N-(2-hydroxyethyl)glycinato(3-)]iron(CAS DataBase Reference)
• NIST Chemistry Reference: [N-[2-[bis(carboxymethyl)amino]ethyl]-N-(2-hydroxyethyl)glycinato(3-)]iron(17084-02-5)
• EPA Substance Registry System: [N-[2-[bis(carboxymethyl)amino]ethyl]-N-(2-hydroxyethyl)glycinato(3-)]iron(17084-02-5)

Safety Data

• Hazardous Substances Data: 17084-02-5(Hazardous Substances Data)

Usage

General Description

[N-[2-[bis(carboxymethyl)amino]ethyl]-N-(2-hydroxyethyl)glycinato(3-)]iron, commonly known as ferric glycine complex, is a coordination complex of iron(III) with the amino acid glycine. This chemical compound is used in pharmaceuticals as an iron supplement for patients with iron-deficiency anemia, as well as a food additive to fortify products with iron. It is known for its high bioavailability and stability, making it an effective way to deliver iron to the body. Additionally, it has been studied for its potential use in the treatment of iron overload disorders, such as hemochromatosis. Overall, ferric glycine complex serves as an important tool in addressing iron deficiencies and related health conditions.

InChI:InChI=1/C10H18N2O7.Fe/c13-4-3-11(5-8(14)15)1-2-12(6-9(16)17)7-10(18)19;/h13H,1-7H2,(H,14,15)(H,16,17)(H,18,19);/q;+2

Upstream product

• 43218-58-2 {Fe(II)(N-(hydroxyethyl)ethylenediaminetriacatate)}^(1-) 

Relevant articles and documents

Electron Spin Resonance Studies of Iron(III) Complexes of Ethylenediamine-tetra-acetate and N-(2-Hydroxyethyl)ethylenediamine-NN'N'-triacetate in Co-ordinating Solvents

Remarkable solvent dependence of the apparent peak-to-peak linewidth (ΔHpp) has been observed for the rhombic type of e.s.r. spectra of the high-spin FeIII(edta) (edta = ethylenediaminetetra-acetate) and FeIII(hedta) hedt

Kinetics and mechanism of the autoxidation of iron(II) induced through chelation by ethylenediaminetetraacetate and related ligands

The oxidation of FeII(L) complexes by molecular oxygen is significantly enhanced by the presence of a chelating ligand L. The kinetics of this reaction was studied for L = ethylenediaminetetraacetate, N-(hydroxyethyl)ethylenediaminetriacetate, and diethylenetriaminepentaacetate as a function of [FeII(L)], [O2], pH, temperature, and pressure. All the observed kinetic relationships can be accounted for in terms of a mechanism in which O2 rapidly reacts with FeII(L) to produce FeII(L)O2, followed by three parallel reaction steps. These include spontaneous and acid-catalyzed electron transfer, as well as a reaction with FeII(L) to produce (L)FeIII-O22--FeIII(L). The results are discussed in reference to the available literature data for these and related oxidation processes.